Related Experiment Video
Updated: Aug 5, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator
H Solomon1, J W Man, G Jackson
1Department of Cardiology, 6th Floor, East Wing, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.
Erectile dysfunction (ED), increasingly common and linked to vascular issues, may indicate underlying cardiovascular disease. Managing cardiovascular risk factors is crucial for preventing and treating ED, even in cardiac patients.
Area of Science:
- Cardiology
- Urology
- Vascular Medicine
Background:
- Erectile dysfunction (ED) is a prevalent condition with projected increases.
- Growing evidence indicates ED is primarily a vascular disease.
- ED may serve as an early indicator of undiagnosed cardiovascular disease.
Purpose of the Study:
- To review the relationship between ED and cardiovascular disease.
- To outline management strategies for ED in patients with cardiovascular disease.
- To emphasize the role of cardiovascular risk factor control in ED prevention.
Main Methods:
- Review of current literature and expert panel guidelines.
- Focus on endothelial dysfunction as a common pathological mechanism.
- Cardiovascular risk stratification for patient management.
Main Results:
- ED is strongly associated with cardiovascular disease, often sharing common vascular pathways.
- Cardiovascular risk factor management is key to ED prevention and treatment.
- Specific guidelines exist for managing ED in cardiac patients.
Conclusions:
- ED is predominantly a vascular condition and a potential marker for occult cardiovascular disease.
- Control of cardiovascular risk factors is essential for ED management.
- ED treatment in low-risk cardiac patients is safe and effective.
More Related Videos
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology

